Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village.

Ossama Ashraf AhmedEslam SafwatMohamed Omar KhalifaAhmed I ElshafieMohamed Hassan Ahmed FouadMohamed Magdy SalamaGina Gamal NaguibMohamed Mahmoud EltabbakhAhmed Fouad SheriefSherief M Abd-Elsalam

Published in: International journal of hepatology (2018)

Sofosbuvir plus Daclatasvir regimen is safe and effective for treatment of chronic hepatitis C Genotype 4 infected patients with minimal adverse events. HCV eradication program implemented in Egypt can be a model for other countries with HCV and limited resources. The availability of generic drugs in Egypt will help much in eradication of the virus.

Keyphrases

hepatitis c virus
human immunodeficiency virus
combination therapy
ejection fraction
newly diagnosed
helicobacter pylori infection
quality improvement
helicobacter pylori
patient reported outcomes
patient reported
hiv infected
smoking cessation
drug induced